Boehringer Ingelheim Pharmaceuticals

A→Z catalog of Boehringer Ingelheim Pharmaceuticals

A

• Adempas — Riociguat — Pulmonary arterial hypertension, CTEPH — 1 mg TID, titrated.

• Atrovent HFA — Ipratropium bromide — COPD, asthma — 2 puffs QID.

• Atrovent Nasal Spray — Ipratropium 0.03–0.06% — Rhinorrhea — 2 sprays/nostril TID–QID.

B

• Basaglar (co-market with Lilly) — Insulin glargine biosimilar — Diabetes — Per basal regimen.

• Berodual — Ipratropium + fenoterol — COPD/asthma — Inhaled TID–QID.

• Berotec — Fenoterol — Bronchodilation — Inhaled PRN.

• Bisolvon — Bromhexine — Mucolytic — 8–16 mg TID.

C

• Cyramza — Ramucirumab — Gastric, NSCLC, CRC, HCC — IV infusion q2w.

• Combivent Respimat — Ipratropium + albuterol — COPD — 1 inhalation QID.

• Codipront (regional legacy) — Codeine + phenylpropanolamine.

• Cough & Cold OTC line (Bisolvon, Mucosolvan).

D

• Daxocox (vet, exclude).

• Dabigatran (Pradaxa) — see P.

E

• Espiriva — (regional spelling of Spiriva).

• Edoxaban is Daiichi Sankyo, not BI (skip).

• Empagliflozin (Jardiance) — see J.

F

• Fasigyn (legacy) — Tinidazole — Protozoal infections — 2 g single dose.

• Flavamed — Ambroxol — Expectorant — 30 mg TID.

G

• Glucobay (regional brand) — Acarbose — Type 2 diabetes — 50–100 mg TID with meals.

H

• Humira biosimilar (Cyltezo, acquired by BI/AbbVie licensing) — Adalimumab-adbm — IMIDs — 40 mg SC q2w.

I

• Idiovian pipeline.

• Influenza vaccines (Fluad, Flucelvax in co-markets).

J

• Jardiance — Empagliflozin — Type 2 diabetes, HFrEF/HFpEF, CKD — 10–25 mg QD.

• Jardiance Duo — Empagliflozin + metformin — T2D — Dosed per combo tablet.

• Jardiance Triple (some markets) — Empagliflozin + linagliptin + metformin.

• Jentadueto — Linagliptin + metformin — T2D — 2.5/1000 mg BID.

• Jardiance Duo XR — Empagliflozin/metformin XR.

K

• Katadolon (regional legacy) — Flupirtine — Pain (limited markets).

• Kinzalmono/Kinzalcombi — Telmisartan ± HCTZ — Hypertension — 40–80 mg QD (mono), with HCTZ 12.5–25 mg.

L

• Lonhala Magnair — Glycopyrrolate inhalation solution — COPD — 25 mcg BID.

• Linagliptin (Tradjenta) — see T.

M

• Micardis — Telmisartan — Hypertension, CV protection — 40–80 mg QD.

• MicardisPlus — Telmisartan + HCTZ — Hypertension — Per tablet strength.

• Mucosolvan — Ambroxol — Mucolytic — 30 mg TID or syrup.

• Metamizole (Novalgin, regional) — Analgesic, antipyretic.

N

• Nintedanib (Ofev) — Nintedanib — Idiopathic pulmonary fibrosis, systemic sclerosis-ILD, progressive pulmonary fibrosis, NSCLC combo — 150 mg BID.

• Nevanac distribution (ophthalmic, co-markets).

• Noxafil distribution (regional legacy).

O

• Ofev — see N.

• Olmetec distribution (regional, legacy with Daiichi Sankyo).

P

• Pradaxa — Dabigatran etexilate — NVAF, VTE prophylaxis & treatment — 150 mg BID (dose adjusted renal/elderly).

• Pradaxa Injection Kit (regional packs).

• Pradaxa 75, 110 mg caps — Region-specific dosing.

• Pradaxa Reversal (Praxbind) — see R.

Q

• Qvintor regional brand.

R

• Respimat platform inhalers — Devices for Spiriva, Stiolto, Striverdi, Combivent.

• Roxane generics (legacy US).

• Roflumilast (Daxas/Daliresp) — PDE4 inhibitor for COPD — 500 mcg QD.

• Roxane Labs generics (legacy BI US unit).

• Roxane Theophylline ER.

• Radicava distribution in Japan (Edaravone; Mitsubishi Tanabe origin).

• Revestive (teduglutide, distribution in some regions).

• Rilmenidine BI regional.

• Ramucirumab (Cyramza) — see C.

• Resolor (prucalopride, regional rights).

• Rekambys (rilpivirine LA injection, Janssen partner).

• Praxbind — Idarucizumab — Dabigatran reversal — 5 g IV once (2 × 2.5 g).

S

• Spiriva HandiHaler/Respimat — Tiotropium bromide — COPD, asthma — 18 mcg inhaled QD (HandiHaler); Respimat 2.5 mcg 2 inhalations QD.

• Stiolto Respimat — Tiotropium + olodaterol — COPD — 2 inhalations QD.

• Striverdi Respimat — Olodaterol — COPD — 2 inhalations QD.

• Synjardy — Empagliflozin + metformin — T2D — BID dosing.

• Synjardy XR — Empagliflozin + metformin XR — QD dosing.

• SyrSpend (regional) — Excipients for peds formulations.

T

• Tradjenta — Linagliptin — T2D — 5 mg QD.

• Trajenta Duo (Jentadueto) — see J.

• Twynsta — Telmisartan + amlodipine — Hypertension — 40/5 mg, 80/5 mg, etc.

U

• Ulisor (regional OTC).

• Ultrahexal distribution.

V

• Virazole (co-distribution legacy) — Ribavirin — RSV, HCV (older) — Inhalation/PO.

• Vargatef (brand for Nintedanib in oncology) — NSCLC — 200 mg BID with docetaxel.

• Viramune — Nevirapine — HIV infection — 200 mg QD ×14d, then BID.

X

• Xovoltib (regional name for afatinib, co-developed).

• Xatral legacy distribution.

Y

• Yentreve — Duloxetine — Stress urinary incontinence (some EU) — 40 mg BID.

Z

• Zelodrin (regional).

• Zyban distribution (bupropion, in some EU markets by BI).